[Pseudomembranous colitis probably caused by Clostridium difficile: first case appeared during preventive treatment of infection of ascitic fluid with norfloxacin].
Tordjman
R
R
Benfiguig
K
K
Eugène
C
C
Mitry
E
E
Merrer
J
J
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D001202:Ascitic Fluid / Q000517:prevention & control*; D016360:Clostridioides difficile / Q000302:isolation & purification*; D003015:Clostridium Infections / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009643:Norfloxacin / Q000009:adverse effects* / Q000627:therapeutic use; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D014640:Vancomycin; D009643:Norfloxacin
Colite pseudo-membraneuse probablement due à Clostridium difficile: premier cas apparu lors d'un traitement préventif de l'infection du liquide d'ascite par la norfloxacine.